119 related articles for article (PubMed ID: 24556851)
1. The increasing prevalence of multiple sclerosis in New Zealand.
Alla S; Pearson J; Debernard L; Miller D; Mason D
Neuroepidemiology; 2014; 42(3):154-60. PubMed ID: 24556851
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis in New Zealand.
Alla S; Mason DF
J Clin Neurosci; 2014 Aug; 21(8):1288-91. PubMed ID: 24503208
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis is more prevalent in northern New Zealand than previously reported.
Chancellor AM; Addidle M; Dawson K
Intern Med J; 2003 Mar; 33(3):79-83. PubMed ID: 12603579
[TBL] [Abstract][Full Text] [Related]
4. MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Taylor BV; Pearson JF; Clarke G; Mason DF; Abernethy DA; Willoughby E; Sabel C
Mult Scler; 2010 Dec; 16(12):1422-31. PubMed ID: 20813774
[TBL] [Abstract][Full Text] [Related]
5. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
[TBL] [Abstract][Full Text] [Related]
6. Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Taylor BV; Palmer A; Simpson S; Lucas R; ; Simmons RD; Mason D; Pearson J; Clarke G; Sabel C; Willoughby E; Richardson A; Abernethy D
Mult Scler; 2013 Oct; 19(12):1627-31. PubMed ID: 23530001
[TBL] [Abstract][Full Text] [Related]
7. Multiple Sclerosis impact on employment and income in New Zealand.
Pearson JF; Alla S; Clarke G; Mason DF; Anderson T; Richardson A; Miller DH; Sabel CE; Abernethy DA; Willoughby EW; Taylor BV
Acta Neurol Scand; 2017 Sep; 136(3):223-232. PubMed ID: 27891575
[TBL] [Abstract][Full Text] [Related]
8. The latitude gradient for multiple sclerosis prevalence is established in the early life course.
Sabel CE; Pearson JF; Mason DF; Willoughby E; Abernethy DA; Taylor BV
Brain; 2021 Aug; 144(7):2038-2046. PubMed ID: 33704407
[TBL] [Abstract][Full Text] [Related]
9. Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?
Koch-Henriksen N; Sorensen PS
J Neurol Sci; 2011 Dec; 311(1-2):58-63. PubMed ID: 21982346
[TBL] [Abstract][Full Text] [Related]
10. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis.
Simpson S; Wang W; Otahal P; Blizzard L; van der Mei IAF; Taylor BV
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1193-1200. PubMed ID: 31217172
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis mortality in New Zealand: a nationwide prospective study.
Leadbetter R; MacAskill M; Myall DJ; Taylor BV; Joshi P; ; Mason DF
J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):511-517. PubMed ID: 36882223
[TBL] [Abstract][Full Text] [Related]
12. High nationwide prevalence of multiple sclerosis in Sweden.
Ahlgren C; Odén A; Lycke J
Mult Scler; 2011 Aug; 17(8):901-8. PubMed ID: 21459810
[TBL] [Abstract][Full Text] [Related]
13. The changing demographic pattern of multiple sclerosis epidemiology.
Koch-Henriksen N; Sørensen PS
Lancet Neurol; 2010 May; 9(5):520-32. PubMed ID: 20398859
[TBL] [Abstract][Full Text] [Related]
14. High prevalence and no latitude gradient of multiple sclerosis in Norway.
Berg-Hansen P; Moen SM; Harbo HF; Celius EG
Mult Scler; 2014 Nov; 20(13):1780-2. PubMed ID: 24603884
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate pneumonitis in rheumatoid arthritis: increased prevalence with increasing latitude: an epidemiological study of trends in new zealand.
Jordan SR; Stevanovic VR; Herbison P; Dockerty J; Highton J
J Clin Rheumatol; 2011 Oct; 17(7):356-7. PubMed ID: 21946458
[TBL] [Abstract][Full Text] [Related]
16. MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review.
Makhani N; Morrow SA; Fisk J; Evans C; Beland SG; Kulaga S; Kingwell E; Marriott JJ; Dykeman J; Jetté N; Pringsheim T; Wolfson C; Marrie RA; Koch MW
Mult Scler Relat Disord; 2014 Jan; 3(1):48-60. PubMed ID: 25877973
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
18. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.
Warren SA; Svenson LW; Warren KG
Mult Scler; 2008 Aug; 14(7):872-9. PubMed ID: 18573834
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway.
Risberg G; Aarseth JH; Nyland H; Lauer K; Myhr KM; Midgard R
Acta Neurol Scand; 2011 Oct; 124(4):250-7. PubMed ID: 21143594
[TBL] [Abstract][Full Text] [Related]
20. Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Otero-Romero S; Roura P; Solà J; Altimiras J; Sastre-Garriga J; Nos C; Vaqué J; Montalban X; Bufill E
Mult Scler; 2013 Feb; 19(2):245-8. PubMed ID: 22546846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
